SCHEMBL6986711

SCHEMBL6986711

N#Cc1cccc(CCC(=O)N2CCCc3cc(N)ccc32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
RIPK1 Q13546 2/20 0.44
TP53 P04637 2/20 0.41
BRD4 O60885 1/20 0.41
ATAD2 Q6PL18 1/20 0.41
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP11B2 P19099 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979722 0.88 TP53 (0.48) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL7959087 0.86 TP53 (0.48) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL6986713 0.83 TSHR (0.41) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL6975443 0.81 TP53 (0.54) TSHRALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7843150 0.80 MAPT (0.54) TSHRALDH1A1MEN1KMT2ATP53
SCHEMBL6983499 0.80 NR3C1 (0.59) KMT2ATP53BRD4LMNANR3C1
SCHEMBL6979462 0.76 MAPT (0.58) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL6986707 0.75 PDK1 (0.44) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL6978707 0.73 MAPT (0.58) TSHRALDH1A1MEN1USP2HPGD
SCHEMBL6977395 0.73 TP53 (0.46) TSHRALDH1A1MEN1USP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed